Welcome to our dedicated page for Hydrofarm Holdings Group SEC filings (Ticker: HYFM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hydrofarm Holdings Group, Inc. SEC filings document the company’s hydroponics equipment and supplies business, public-company governance and capital structure. Form 8-K reports cover operating results, material agreements, credit arrangements, revolving-credit termination, forbearance matters, auditor changes, executive and board transitions, and Nasdaq continued-listing compliance notices.
Proxy filings describe director elections, board committee matters, executive compensation and equity-award disclosures. The filing record also addresses liquidity, stockholders’ equity, risk factors, financial reporting controls and the debt obligations tied to Hydrofarm’s role as a branded manufacturer and distributor serving controlled environment agriculture markets.
Hydrofarm Holdings Group, Inc. held its 2026 annual meeting of stockholders via webcast on June 23, 2026. Of 4,764,612 common shares eligible to vote as of April 24, 2026, 2,642,956 shares were present or represented by proxy, representing a 55.47% quorum.
Stockholders elected Richard Christopher Yetter as a Class III director to serve until the 2029 annual meeting. They also approved, on an advisory basis, the compensation of the company’s named executive officers and ratified the appointment of CBIZ CPAs P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Yetter Richard Christopher reported acquisition or exercise transactions in this Form 4 filing.
HYDROFARM HOLDINGS GROUP, INC. director Richard Christopher Yetter reported updated holdings and a new equity grant. An entity associated with him, Dumont Master Fund LP, holds 305,000 shares indirectly. Yetter also received a grant of 30,000 restricted stock units that vest on June 23, 2027, bringing his direct common stock holdings to 50,000 shares. He disclaims beneficial ownership of certain reported securities except to the extent of his pecuniary interest.
Chung Patrick reported acquisition or exercise transactions in this Form 4 filing.
HYDROFARM HOLDINGS GROUP, INC. director Patrick Chung reported receiving an equity compensation award. He was granted 30,000 shares of common stock in the form of restricted stock units under the company’s 2020 Equity Incentive Plan, which will vest on June 23, 2027. Following this grant, Chung holds a reported total of 91,148 shares of common stock, reflecting a routine, non‑cash increase in his direct ownership tied to long-term incentives rather than an open-market purchase.
Persofsky Renah reported acquisition or exercise transactions in this Form 4 filing.
HYDROFARM HOLDINGS GROUP, INC. director Renah Persofsky received an equity award of 30,000 shares of common stock in the form of restricted stock units. These RSUs were granted under the company’s 2020 Equity Incentive Plan and are scheduled to vest on June 23, 2027.
Following this grant, Persofsky’s direct holdings reported in this filing total 91,498 shares of common stock. This is a compensation-related award at no cash cost per share, rather than an open-market purchase.
HYDROFARM HOLDINGS GROUP, INC. director Melisa Denis reported an equity compensation grant. Denis acquired 30,000 shares of common stock in the form of restricted stock units under the company’s 2020 Equity Incentive Plan, at a stated price of $0.00 per share.
The 30,000 restricted stock units are scheduled to vest on June 23, 2027, meaning they will deliver shares only if the vesting conditions are met and Denis remains eligible. Following this award, Denis directly holds 88,423 shares of Hydrofarm common stock.
Hydrofarm Holdings Group, Inc. received an extension from Nasdaq to regain compliance with Nasdaq Listing Rule 5550(b), which sets minimum standards for stockholders’ equity, market value and net income. The company must demonstrate compliance when it files its report for the three months ended September 30, 2026, or it may face delisting, with the option to appeal to a Nasdaq Hearings Panel.
The extension is conditioned on Hydrofarm entering into definitive agreements for certain strategic transactions and publicly reporting how these actions resolve its stockholders’ equity deficiency, potentially including a recent balance sheet with pro forma adjustments. The company cautions there is no assurance it will regain or maintain compliance, and highlights risks related to liquidity, indebtedness, industry conditions and access to capital.
Hydrofarm Holdings Group reported weak first-quarter 2026 results as industry oversupply continued to pressure its business. Net sales fell 29.6% to $28.5 million, and net loss was $14.6 million, or $(3.07) per diluted share.
Gross profit dropped to $1.8 million, or 6.4% of net sales, while Adjusted EBITDA declined to $(3.9) million. Despite cutting SG&A to $10.6 million and improving Free Cash Flow to $(0.8) million, the balance sheet remains strained with a term loan principal of $114.4 million and total stockholders’ deficit of $(78.1) million.
Hydrofarm missed a $2.8 million interest payment on its term loan in February, triggering an event of default. The company is now operating under an April 2026 Forbearance Agreement that imposes a $1 million minimum liquidity threshold, while management and the board pursue strategic alternatives to strengthen liquidity and the capital structure.
Hydrofarm Holdings Group, Inc. is soliciting proxies for its 2026 virtual annual stockholder meeting, where investors will elect one Class III director, cast an advisory vote on executive compensation and ratify CBIZ CPAs P.C. as auditor for 2026. The proxy details board structure, committee independence, ownership levels and employment terms for senior executives, including CEO William Toler. It also discloses that 2025 net sales declined 29% versus 2024 and that the company recorded $232 million of impairment charges. A February 2026 event of default on its Term Loan "raised substantial doubt" about Hydrofarm’s ability to continue as a going concern, which frames how the board approaches pay, retention awards and risk oversight.